Astilbin ameliorates oxidative stress and apoptosis in D-galactose-induced senescence by regulating the PI3K/Akt/m-TOR signaling pathway in the brains of mice

Int Immunopharmacol. 2021 Oct:99:108035. doi: 10.1016/j.intimp.2021.108035. Epub 2021 Aug 12.

Abstract

An increasing amount of evidence has shown that injection of D-galactose (D-gal) can mimic natural aging that typically is associated with brain injury. Oxidative stress and apoptosis has been shown to play an essential role in aging process. The purpose of this study was to investigate the protective effectsof astilbin (ASB) on D-Gal-induced agingin miceand to further explore the underlying mechanisms. We randomly divided 50 mice into 5 groups.To establish this model of aging, 40micewere intraperitoneally administered D-Gal (500 mg/kg). The mice in the treatmentgroupswere intragastricaly administratedASB at doses of 40 and 80 mg/kg. H&E and TUNEL staining were used to determine the effect of ASB on the number of apoptotic cells in the brain. Furthermore, biochemical indices of serum, oxidative stress factors, and apoptosis factors were determined to clarify the underlying mechanism using reagent test kits and western blotting. The results showed that varying doses of ASB could improve D-Gal-induced histopathological damageand significantly alleviatedthe aging induced by D-Galin mice. ASB remarkably decreased the activities of malondialdehyde (MDA)(p < 0.01)and Acetyl cholinesterase (AChE)(p < 0.05) and markedlyincreased the content of catalase (CAT)(p < 0.01)and superoxide dismutase (SOD)(p < 0.01), respectively. In addition, Western blotting revealed thatASB treatment (40 mg/kg)attenuated the D-gal-induced Bax and Caspase 3 protein expression(p < 0.01) and reversed the increase in Bcl-2protein expressionin brain. Moreover, ASB treatment significantly upregulated the protein expression ofp-PI3K/PI3K and altered the p-Akt/Akt ratio (p < 0.05), while inhibiting the expression of p-m-TOR relative to m-TOR(p < 0.05). Moreover, the expression of P53 tended to decreasein the low ASB treatmentgroup (40 mg/kg), whereas no change was observed in the high ASB treatmentgroup (80 mg/kg). In the intestinal flora, the richness of the normal group and the ASB group was higher than that of the D-Gal group. Heat map analysis also showed that ASB promoted Lactobacillus and other probiotics and also confirmed the advantages of ASB. The observed changes in intestinal flora further verified the efficacy of ASB.

Keywords: Aging; Astilbin; D-galactose; Oxidative stress; PI3K/Akt/m-TOR signaling pathway.

Publication types

  • Comparative Study

MeSH terms

  • Acetylcholinesterase / metabolism
  • Aging / drug effects*
  • Aging / metabolism
  • Animals
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Apoptosis / drug effects
  • Ascorbic Acid / pharmacology
  • Ascorbic Acid / therapeutic use
  • Body Weight / drug effects
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / pathology
  • Catalase / metabolism
  • Disease Models, Animal
  • Flavonols / pharmacology*
  • Flavonols / therapeutic use
  • Galactose / toxicity
  • Gastrointestinal Microbiome / drug effects
  • Male
  • Malondialdehyde / metabolism
  • Mice
  • Mice, Inbred ICR
  • Oxidative Stress / drug effects
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction / drug effects
  • Superoxide Dismutase / metabolism
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Antioxidants
  • Flavonols
  • astilbin
  • Malondialdehyde
  • Catalase
  • Superoxide Dismutase
  • mTOR protein, mouse
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Acetylcholinesterase
  • Ascorbic Acid
  • Galactose